Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02686671 · ClinicalTrials.gov registry record
The Pull Test To Determine Responders To Subacromial Injection In Patients With Shoulder Impingement
A clinical trial, sponsored by Texas Tech University Health Sciences Center.
- Completed
- Registry status
- 38
- Enrollment target
NCT02686671 is a clinical trial that has completed, run by Texas Tech University Health Sciences Center. The registered enrollment target is 38 participants.
The verdict
NCT02686671 has completed, sponsored by Texas Tech University Health Sciences Center.
- COMPLETED
- Registry status
- 38 participants
- Enrollment target
Study Summary
Shoulder pain is very common. People receive injections in their shoulder for their painful shoulder. However, investigators do not know which patient with shoulder pain responds best to an injection in the shoulder. Investigators plan to use a "Pull Test" where the researcher will pull on the arm and resist shoulder movement to investigate if it helps to determine which patients have better pain relief with the shoulder injection. The study will take place in Anchorage, Alaska. There will be two phases in the study. For each phase, the subjects will complete some questionnaires. Phase I "Reliability Testing" will test how consistent two licensed physical therapists are giving shoulder examination tests and the Pull Test. Phase II "Pull Test" will comprise shoulder examination findings, including the Pull Test, done before and after one shoulder injection performed as normal standard of care by a licensed physician. For Phase I of the study, up to 20 patients treated for shoulder pain will be recruited from Advanced Physical Therapy. For Phase II of the study, up to 100 patients with shoulder pain scheduled to have a shoulder injection will be asked by an investigator if they wish to participate in the study until a number of 30 subjects qualify for the study. Phase II of the study will include shoulder tests before and about 20 minutes after the injection and a 4- to 7-day, as well as a 6-week, phone follow-up. Statistics will be used to analyze the data.
Interventions
- OTHER Shoulder clinical examination testing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2016-03 |
| Est. Completion | 2018-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02686671
The ClinicalTrials.gov registry entry for NCT02686671 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Texas Tech University Health Sciences Center, which has 76 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shoulder clinical examination testing is the first listed.
NCT02686671 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02686671 about?
NCT02686671 is a clinical study titled "The Pull Test To Determine Responders To Subacromial Injection In Patients With Shoulder Impingement". Shoulder pain is very common. People receive injections in their shoulder for their painful shoulder. However, investigators do not know which patient with shoulder pain responds best to an injection in the shoulder. Investigators plan to use a "Pull Test" where the researcher will pull on the arm ...
What is the current status of trial NCT02686671?
This trial is currently completed. The enrollment target is 38 participants. The study started on 2016-03. Estimated completion is 2018-12.
What interventions are being tested in trial NCT02686671?
The interventions under investigation include: Shoulder clinical examination testing (OTHER).
Who is sponsoring clinical trial NCT02686671?
This trial is sponsored by Texas Tech University Health Sciences Center, which has 76 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.